Wegovy® (semaglutide) is an effective injectable weight loss drug for people with a BMI over 30. It is also available for people with a BMI over 27 who have additional weight-related health concerns, such as high blood pressure, type 2 diabetes, heart disease, and raised cholesterol.

Wegovy® mimics a natural hormone in the gut that helps control your appetite and makes you feel fuller, aiding in weight loss when combined with a reduced-calorie diet and increased physical activity.

Wegovy® is an injectable medication that comes in a pre-filled pen. It should be used once weekly on the same day each week. The pen is simple to use, with very small needles making it relatively pain-free. You can inject Wegovy® into the abdomen, thigh, or upper arm, at any time during the day, with or without food. Instructions are provided with your first order, and additional information is available on the Wegovy® website, including a helpful video on how to use Wegovy®.

Wegovy® is suitable for adults with a BMI over 30, or a BMI over 27 with weight-related health concerns such as high blood pressure, diabetes, heart disease, and raised cholesterol. It cannot be prescribed for weight loss to individuals with type 2 diabetes and a BMI less than 27.

Your treatment starts at a low dose and increases every four weeks. The starting dose is 0.25 mg once a week for four weeks. The dose is then increased every four weeks until reaching the recommended dose of 2.4 mg a week. After six months of treatment, your weight will be reviewed to ensure effectiveness, with a requirement to have lost around 5% of your initial body weight for continued prescription.

Wegovy® is one of the most effective weight loss treatments, with over 85% of users experiencing weight loss. Two-thirds of participants lose more than 10% of their body weight, and nearly one-third lose more than 20%. On average, users lose more than 15 kg.